Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 86

1.

An investigation of the symmetric and asymmetric cleavage products in the system aluminum trihalide - 1-butylimidazole.

Hog MS, Schneider M, Studer G, Bäuerle M, Föhrenbacher SA, Scherer H, Krossing I.

Chemistry. 2017 Jun 13. doi: 10.1002/chem.201701553. [Epub ahead of print]

PMID:
28608508
2.

Local control and intermediate-term cosmetic outcome following IMRT for nasal tumors : An update.

Mukai Y, Janssen S, Glanzmann C, Holzmann D, Studer G.

Strahlenther Onkol. 2017 Apr;193(4):295-304. doi: 10.1007/s00066-016-1083-8. Epub 2016 Dec 5.

PMID:
27921123
3.

The SWISS-MODEL Repository-new features and functionality.

Bienert S, Waterhouse A, de Beer TA, Tauriello G, Studer G, Bordoli L, Schwede T.

Nucleic Acids Res. 2017 Jan 4;45(D1):D313-D319. doi: 10.1093/nar/gkw1132. Epub 2016 Nov 29.

4.

Stability of radiomic features in CT perfusion maps.

Bogowicz M, Riesterer O, Bundschuh RA, Veit-Haibach P, Hüllner M, Studer G, Stieb S, Glatz S, Pruschy M, Guckenberger M, Tanadini-Lang S.

Phys Med Biol. 2016 Dec 21;61(24):8736-8749. Epub 2016 Nov 28.

PMID:
27893446
5.

Expression of CK19 is an independent predictor of negative outcome for patients with squamous cell carcinoma of the tongue.

Ernst J, Ikenberg K, Apel B, Schumann DM, Huber G, Studer G, Rordorf T, Riesterer O, Rössle M, Korol D, Bredell MG.

Oncotarget. 2016 Nov 15;7(46):76151-76158. doi: 10.18632/oncotarget.12691.

6.

Haemoglobin and creatinine values as prognostic factors for outcome of concurrent radiochemotherapy in locally advanced head and neck cancers : Secondary results of two European randomized phase III trials (ARO 95-06, SAKK 10/94).

Ghadjar P, Pöttgen C, Joos D, Hayoz S, Baumann M, Bodis S, Budach W, Studer G, Stromberger C, Zimmermann F, Kaul D, Plasswilm L, Olze H, Bernier J, Wust P, Aebersold DM, Budach V.

Strahlenther Onkol. 2016 Aug;192(8):552-60. doi: 10.1007/s00066-016-0999-3. Epub 2016 Jun 20.

PMID:
27323753
7.

IMRT/VMAT for malignancies in the head-and-neck region : Outcome in patients aged 80.

Brown ML, Glanzmann C, Huber G, Bredell M, Rordorf T, Studer G.

Strahlenther Onkol. 2016 Aug;192(8):526-36. doi: 10.1007/s00066-016-0986-8. Epub 2016 Jun 15.

8.

Hypofractionated Radiotherapy for Breast Cancer Including Risk-adapted Boost: Update on Tolerance and Efficacy of an Accelerated START A Regime.

Janssen S, Glanzmann C, Lang S, Verlaan S, Streller T, Linsenmeier C, Rades D, Studer G.

Anticancer Res. 2016 May;36(5):2513-22.

PMID:
27127166
9.

Does airway intervention before primary nonsurgical therapy for T3/T4 laryngeal squamous cell carcinoma impact on oncological or functional outcomes?

Schariatzadeh R, Pezier TF, Studer G, Schmid S, Huber GF.

Swiss Med Wkly. 2015 Nov 23;145:w14213. doi: 10.4414/smw.2015.14213. eCollection 2015.

10.

Combined PET/CT-perfusion in patients with head and neck cancers might predict failure after radio-chemotherapy: a proof of concept study.

Pietsch C, de Galiza Barbosa F, Hüllner MW, Schmid DT, Haerle SK, Huber GF, Studer G, Hany TF, Veit-Haibach P.

BMC Med Imaging. 2015 Dec 29;15:60. doi: 10.1186/s12880-015-0102-z.

11.

Evaluation of an automated knowledge based treatment planning system for head and neck.

Krayenbuehl J, Norton I, Studer G, Guckenberger M.

Radiat Oncol. 2015 Nov 10;10:226. doi: 10.1186/s13014-015-0533-2.

12.

Tumor stage, tumor site and HPV dependent correlation of perfusion CT parameters and [18F]-FDG uptake in head and neck squamous cell carcinoma.

Nesteruk M, Lang S, Veit-Haibach P, Studer G, Stieb S, Glatz S, Hemmatazad H, Ikenberg K, Huber G, Pruschy M, Guckenberger M, Klöck S, Riesterer O.

Radiother Oncol. 2015 Oct;117(1):125-31. doi: 10.1016/j.radonc.2015.09.026.

PMID:
26452710
13.

Risk profile for osteoradionecrosis of the mandible in the IMRT era.

Studer G, Bredell M, Studer S, Huber G, Glanzmann C.

Strahlenther Onkol. 2016 Jan;192(1):32-9. doi: 10.1007/s00066-015-0875-6. Epub 2015 Aug 12.

14.

Radiation-induced lower cranial nerve palsy in patients with head and neck carcinoma.

Janssen S, Glanzmann C, Yousefi B, Loewenich K, Huber G, Schmid S, Studer G.

Mol Clin Oncol. 2015 Jul;3(4):811-816. Epub 2015 May 4.

15.

Nipple-sparing mastectomy in breast cancer patients: The role of adjuvant radiotherapy (Review).

Janssen S, Holz-Sapra E, Rades D, Moser A, Studer G.

Oncol Lett. 2015 Jun;9(6):2435-2441. Epub 2015 Mar 27.

16.

Less may be more: nodal treatment in neck positive head neck cancer patients.

Studer G, Huber GF, Holz E, Glanzmann C.

Eur Arch Otorhinolaryngol. 2016 Jun;273(6):1549-56. doi: 10.1007/s00405-015-3634-5. Epub 2015 Apr 29.

17.

Impact of weight loss on survival after chemoradiation for locally advanced head and neck cancer: secondary results of a randomized phase III trial (SAKK 10/94).

Ghadjar P, Hayoz S, Zimmermann F, Bodis S, Kaul D, Badakhshi H, Bernier J, Studer G, Plasswilm L, Budach V, Aebersold DM; Swiss Group for Clinical Cancer Research (SAKK).

Radiat Oncol. 2015 Jan 17;10:21. doi: 10.1186/s13014-014-0319-y.

18.

Carotid artery disease after head and neck radiotherapy.

Thalhammer C, Husmann M, Glanzmann C, Studer G, Amann-Vesti BR.

Vasa. 2015 Jan;44(1):23-30. doi: 10.1024/0301-1526/a000403. Review.

PMID:
25537055
19.

Simultaneous analysis of large-scale RNAi screens for pathogen entry.

Rämö P, Drewek A, Arrieumerlou C, Beerenwinkel N, Ben-Tekaya H, Cardel B, Casanova A, Conde-Alvarez R, Cossart P, Csúcs G, Eicher S, Emmenlauer M, Greber U, Hardt WD, Helenius A, Kasper C, Kaufmann A, Kreibich S, Kühbacher A, Kunszt P, Low SH, Mercer J, Mudrak D, Muntwiler S, Pelkmans L, Pizarro-Cerdá J, Podvinec M, Pujadas E, Rinn B, Rouilly V, Schmich F, Siebourg-Polster J, Snijder B, Stebler M, Studer G, Szczurek E, Truttmann M, von Mering C, Vonderheit A, Yakimovich A, Bühlmann P, Dehio C.

BMC Genomics. 2014 Dec 22;15:1162. doi: 10.1186/1471-2164-15-1162.

20.

PTV margin definition in hypofractionated IGRT of localized prostate cancer using cone beam CT and orthogonal image pairs with fiducial markers.

Oehler C, Lang S, Dimmerling P, Bolesch C, Kloeck S, Tini A, Glanzmann C, Najafi Y, Studer G, Zwahlen DR.

Radiat Oncol. 2014 Nov 11;9:229. doi: 10.1186/s13014-014-0229-z.

Supplemental Content

Loading ...
Support Center